CL2014003373A1 - Anticuerpos monoclonales especificos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares , útiles para la deteccion y el diagnostico de la infeccion causada por hmpv. - Google Patents

Anticuerpos monoclonales especificos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares , útiles para la deteccion y el diagnostico de la infeccion causada por hmpv.

Info

Publication number
CL2014003373A1
CL2014003373A1 CL2014003373A CL2014003373A CL2014003373A1 CL 2014003373 A1 CL2014003373 A1 CL 2014003373A1 CL 2014003373 A CL2014003373 A CL 2014003373A CL 2014003373 A CL2014003373 A CL 2014003373A CL 2014003373 A1 CL2014003373 A1 CL 2014003373A1
Authority
CL
Chile
Prior art keywords
hmpv
hybridomas
secreted
antigen
diagnosis
Prior art date
Application number
CL2014003373A
Other languages
English (en)
Inventor
Ramirez Susan Marcela Bueno
Parra Alexis Mikes Kalergis
Alarcon Jorge Eugenio Mora
Original Assignee
Univ Pontificia Catolica Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pontificia Catolica Chile filed Critical Univ Pontificia Catolica Chile
Priority to CL2014003373A priority Critical patent/CL2014003373A1/es
Priority to PE2017000986A priority patent/PE20171734A1/es
Priority to KR1020177019261A priority patent/KR102339334B1/ko
Priority to RU2017120228A priority patent/RU2698052C2/ru
Priority to GB1709129.9A priority patent/GB2547603B/en
Priority to CN201580073977.9A priority patent/CN107207584B/zh
Priority to PCT/IB2015/050790 priority patent/WO2016092380A1/es
Priority to EP18188183.0A priority patent/EP3495386A1/en
Priority to GB1901874.6A priority patent/GB2568617A/en
Priority to BR112017012511-0A priority patent/BR112017012511B1/pt
Priority to CA2970482A priority patent/CA2970482A1/en
Priority to MX2017007611A priority patent/MX2017007611A/es
Priority to EP15866549.7A priority patent/EP3231815A4/en
Priority to US15/535,170 priority patent/US9995747B2/en
Priority to DE112015005539.8T priority patent/DE112015005539T5/de
Priority to CA3168348A priority patent/CA3168348A1/en
Publication of CL2014003373A1 publication Critical patent/CL2014003373A1/es
Priority to ARP150104031A priority patent/AR102966A1/es
Priority to UY0001036431A priority patent/UY36431A/es
Priority to CONC2017/0005781A priority patent/CO2017005781A2/es
Priority to ZA2017/04530A priority patent/ZA201704530B/en
Priority to ZA2018/04550A priority patent/ZA201804550B/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027Paramyxoviridae, e.g. respiratory syncytial virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/115Paramyxoviridae, e.g. parainfluenza virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CL2014003373A 2014-12-11 2014-12-11 Anticuerpos monoclonales especificos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares , útiles para la deteccion y el diagnostico de la infeccion causada por hmpv. CL2014003373A1 (es)

Priority Applications (21)

Application Number Priority Date Filing Date Title
CL2014003373A CL2014003373A1 (es) 2014-12-11 2014-12-11 Anticuerpos monoclonales especificos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares , útiles para la deteccion y el diagnostico de la infeccion causada por hmpv.
BR112017012511-0A BR112017012511B1 (pt) 2014-12-11 2015-02-02 Anticorpo monoclonal ou um fragmento do mesmo, método de diagnóstico in vitro e/ou ex vivo para a infecção por hmpv e kit de diagnóstico para a detecção de hmpv
EP15866549.7A EP3231815A4 (en) 2014-12-11 2015-02-02 Specific monoclonal antibodies of the antigen m of the human metapneumovirus (hmpv) and use thereof in a diagnostic method
RU2017120228A RU2698052C2 (ru) 2014-12-11 2015-02-02 Особые моноклональные антитела антигена м метапневмовируса человека (hmpv) и способ их использования в методе диагностики
GB1709129.9A GB2547603B (en) 2014-12-11 2015-02-02 Specific monoclonal antibodies of the antigen M of the human metapneumovirus (HMPV) and use thereof in a diagnostic method
CN201580073977.9A CN107207584B (zh) 2014-12-11 2015-02-02 人偏肺病毒(hmpv)的m抗原的特异性单克隆抗体及其在诊断方法中的用途
PCT/IB2015/050790 WO2016092380A1 (es) 2014-12-11 2015-02-02 Anticuerpos monoclonales especificos del antigeno m del virus metapneumovirus humano (hmpv) y su uso en un metodo de diagnostico
EP18188183.0A EP3495386A1 (en) 2014-12-11 2015-02-02 Specific monoclonal antibodies of the antigen m of the human metapneumovirus (hmpv) and use thereof in a diagnostic method
GB1901874.6A GB2568617A (en) 2014-12-11 2015-02-02 Specific monoclonal antibodies of the antigen M of the human metapneumovirus (HMPV), and use thereof in a diagnostic method
PE2017000986A PE20171734A1 (es) 2014-12-11 2015-02-02 Anticuerpos monoclonales especificos del antigeno m del virus metapneumovirus humano (hmpv) y su uso en un metodo de diagnostico
CA2970482A CA2970482A1 (en) 2014-12-11 2015-02-02 Specific monoclonal antibodies of the antigen m of the human metapneumovirus (hmpv), and use thereof in a diagnostic method
MX2017007611A MX2017007611A (es) 2014-12-11 2015-02-02 Anticuerpos monoclonales especificos del antigeno m del virus metapneumovirus humano (hmpv) y su uso en un metodo de diagnostico.
KR1020177019261A KR102339334B1 (ko) 2014-12-11 2015-02-02 인간 메타뉴모바이러스(hMPV)의 항원 M의 특이적 단클론 항체 및 진단 방법에 있어서의 그 용도
US15/535,170 US9995747B2 (en) 2014-12-11 2015-02-02 Specific monoclonal antibodies of the antigen M of the human metapneumovirus (HMPV) and use thereof in a diagnostic method
DE112015005539.8T DE112015005539T5 (de) 2014-12-11 2015-02-02 Spezifische monoklonale Antikörper des M-Antigens des Human-Metapneumvirus (HMPV) und deren Verwendung in einem Diagnoseverfahren
CA3168348A CA3168348A1 (en) 2014-12-11 2015-02-02 Specific monoclonal antibodies of the antigen m of the human metapneumovirus (hmpv), and use thereof in a diagnostic method
ARP150104031A AR102966A1 (es) 2014-12-11 2015-12-10 ANTICUERPOS MONOCLONALES ESPECÍFICOS PARA EL ANTÍGENO M DEL VIRUS METAPNEUMOVIRUS HUMANO (hMPV), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, ÚTILES PARA LA DETECCIÓN Y EL DIAGNÓSTICO DE LA INFECCIÓN CAUSADA POR hMPV
UY0001036431A UY36431A (es) 2014-12-11 2015-12-11 Anticuerpos monoclonales específicos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por hmpv
CONC2017/0005781A CO2017005781A2 (es) 2014-12-11 2017-06-12 Anticuerpos monoclonales especificos del antigeno m del virus metapneumovirus humano (hmpv) y metodo de diagnostico que involucra el mismo
ZA2017/04530A ZA201704530B (en) 2014-12-11 2017-07-04 Specific monoclonal antibodies of the antigen m of the human metapneumovirus (hmpv) and use thereof in a diagnostic method
ZA2018/04550A ZA201804550B (en) 2014-12-11 2018-07-09 Specific monoclonal antibodies of the antigen m of the human metapneumovirus (hmpv) and use thereof in a diagnostic method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2014003373A CL2014003373A1 (es) 2014-12-11 2014-12-11 Anticuerpos monoclonales especificos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares , útiles para la deteccion y el diagnostico de la infeccion causada por hmpv.

Publications (1)

Publication Number Publication Date
CL2014003373A1 true CL2014003373A1 (es) 2015-04-10

Family

ID=53404103

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014003373A CL2014003373A1 (es) 2014-12-11 2014-12-11 Anticuerpos monoclonales especificos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares , útiles para la deteccion y el diagnostico de la infeccion causada por hmpv.

Country Status (17)

Country Link
US (1) US9995747B2 (es)
EP (2) EP3495386A1 (es)
KR (1) KR102339334B1 (es)
CN (1) CN107207584B (es)
AR (1) AR102966A1 (es)
BR (1) BR112017012511B1 (es)
CA (2) CA2970482A1 (es)
CL (1) CL2014003373A1 (es)
CO (1) CO2017005781A2 (es)
DE (1) DE112015005539T5 (es)
GB (2) GB2547603B (es)
MX (1) MX2017007611A (es)
PE (1) PE20171734A1 (es)
RU (1) RU2698052C2 (es)
UY (1) UY36431A (es)
WO (1) WO2016092380A1 (es)
ZA (2) ZA201704530B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112912394B (zh) * 2018-09-03 2024-04-16 智利天主教教皇大学 针对hrsv的n抗原的单抗,可用于治疗感染、其检测和诊断
JP7274904B2 (ja) * 2019-03-26 2023-05-17 田中貴金属工業株式会社 ヒトメタニューモウイルス検出用試薬

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007525178A (ja) * 2003-04-25 2007-09-06 メッドイミューン バクシーンズ,インコーポレイティド メタニューモウイルス株、そのワクチン製剤における用途、抗原性配列の発現のためのベクターとしての用途、並びにウイルス増殖方法
EP1473037A1 (en) * 2003-05-02 2004-11-03 Vironovative B.V. Treatment of hPMV infections with Ribavirin
CA2624291A1 (en) * 2005-10-03 2007-04-12 Seneca College Of Applied Arts & Technology Nucleic acid immunological composition for human metapneumovirus
US8492097B2 (en) * 2006-04-24 2013-07-23 Diagnostic Hybrids, Inc. Compositions and methods for human metapneumovirus monoclonal antibodies
US20110135645A1 (en) * 2006-10-04 2011-06-09 The Scripps Research Institute Human antibodies neutralizing human metapneumovirus
WO2008148170A1 (en) * 2007-06-08 2008-12-11 The University Of Queensland Human metapneumovirus immunogenic peptides, compositions, and methods of use
CN102145167A (zh) * 2010-02-05 2011-08-10 重庆医科大学附属儿童医院 重组人类偏肺病毒疫苗
CL2011003002A1 (es) * 2011-11-25 2012-05-25 Univ Pontificia Catolica Chile Anticuerpo monoclonal o un fragmento del mismo que se une a la proteina m2-1 del virus respiratorio sincicial (vrs) humano; secuencias nucleotidicas; composicion farmaceutica; metodo de diagnostico de infeccion producida por vrs; kit; y uso de dicho anticuerpo para preparar un medicamento.

Also Published As

Publication number Publication date
EP3231815A4 (en) 2018-02-21
AR102966A1 (es) 2017-04-05
US9995747B2 (en) 2018-06-12
MX2017007611A (es) 2017-09-18
ZA201804550B (en) 2019-09-25
CA3168348A1 (en) 2016-06-16
EP3495386A1 (en) 2019-06-12
CN107207584B (zh) 2021-01-08
KR102339334B1 (ko) 2021-12-14
DE112015005539T5 (de) 2017-08-31
ZA201704530B (en) 2018-11-28
US20170343546A1 (en) 2017-11-30
BR112017012511A2 (pt) 2018-02-27
CA2970482A1 (en) 2016-06-16
CN107207584A (zh) 2017-09-26
GB2547603B (en) 2019-10-30
PE20171734A1 (es) 2017-12-04
CO2017005781A2 (es) 2017-08-31
GB2568617A (en) 2019-05-22
RU2698052C2 (ru) 2019-08-21
WO2016092380A1 (es) 2016-06-16
UY36431A (es) 2016-01-29
RU2017120228A (ru) 2019-01-11
BR112017012511B1 (pt) 2023-12-12
GB201709129D0 (en) 2017-07-26
GB2547603A (en) 2017-08-23
RU2017120228A3 (es) 2019-01-11
EP3231815A1 (en) 2017-10-18
KR20170086668A (ko) 2017-07-26
GB201901874D0 (en) 2019-04-03

Similar Documents

Publication Publication Date Title
CY1122804T1 (el) Μονοκλωνικα αντισωματα εναντι ανθρωπινου αντιγονου ωριμανσης β κυτταρων (βcμα)
CL2015002152A1 (es) Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh
CO2017005784A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
CL2017001610A1 (es) Anticuerpos humanos para hemagglutinina de influenza
CL2017000545A1 (es) Anticuerpos anti-her2 e inmunoconjugados
BR112017007170A2 (pt) anticorpos anti-ox40 humanizados e suas utilizações
EA201500995A1 (ru) Биспецифические антитела, специфические в отношении fap и dr5, антитела, специфические в отношении dr5, и способы их применения
DK3309174T3 (da) ANTI-PD-L1-antistoffer og diagnostiske anvendelser deraf
EA201691991A1 (ru) Мультиспецифические антитела
EA201790984A1 (ru) Анти-cd79b антитела и способы их применения
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
CO2017007121A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
CR20160270A (es) ANTICUERPOS ANTI-TAU (pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN
UY36905A (es) Anticuerpos neutralizantes de poliomavirus
BR112017009817A2 (pt) anticorpos anti-il-1beta e métodos de utilização
EA201591973A1 (ru) Антитела человека, связывающиеся с g-белком rsv
DK3166973T3 (da) Immunstimulerende monoklonale antistoffer mod human interleukin-2
EA201691473A1 (ru) Биспецифические анти-il-13/il-17 антитела и их применение
BR112017015880A2 (pt) anticorpos, usos e métodos
CO2017010621A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
ZA201804705B (en) Monoclonal antibodies specific for the piii antigen of human adenovirus (adv), produced and secreted by cell hybridomas, useful for detection and diagnosis of adv infection
BR112016029935A2 (pt) ?anticorpos anti-brdu, complexo, formulação farmacêutica e uso de anticorpo?
CL2014003373A1 (es) Anticuerpos monoclonales especificos para el antígeno m del virus metapneumovirus humano (hmpv), producidos y secretados por hibridomas celulares , útiles para la deteccion y el diagnostico de la infeccion causada por hmpv.
BR112017021413A2 (pt) anticorpos anti-flt-1 no tratamento da displasia broncopulmonar.
CL2016003038A1 (es) Dispositivo y procedimiento para la determinación de antígenos de grupo sanguíneo con un anticuerpo incompleto.